Modification by two beta-adrenergic blocking drugs of the effects of methamphetamine on behaviour and brain metabolism of mice.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001786:Blood Glucose; D001921:Brain / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008694:Methamphetamine / Q000037:antagonists & inhibitors*; D009043:Motor Activity / Q000187:drug effects*; D010725:Phosphocreatine / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007773:Lactates; D011773:Pyruvates; D013565:Sympatholytics; D010725:Phosphocreatine; D008694:Methamphetamine; D000255:Adenosine Triphosphate; D006003:Glycogen; D011433:Propranolol; D005947:Glucose